Form 10-12B
We note your disclosure here that you "intend to apply to list Company Shares on the (the “Stock Exchange”)." We also note your disclosure on page 5 that Parent may waive any of the conditions for closing, one of which is that "The Stock Exchange will have approved the listing of the Company' Shares, subject to official notice of issuance." Please revise your cover page to clarify whether the spinoff is contingentRest of the question
upon The Stock Exchange's approval of your listing application.
No reply letter found.
Your statements that: (i) the estimated market and industry data included in this information statement is inherently uncertain and imprecise; and (ii) investors are cautioned not to place undue reliance on such market and industry data or any other such estimates may imply an inappropriate disclaimer of responsibility with respect to the third-party information.Rest of the question
Please either delete these statements or specifically state that you are liable for such information.
No reply letter found.
We note your disclosure on pages 2 and 92 that you "have a strategy of accelerated growth to achieve our ambition of $20 billion in revenues and more than $5 billion of Adjusted EBITDA by 2030." If you choose to retain these projections, please revise your document to disclose management's reasonable basis for these projections.Rest of the question
Also, disclose any underlying assumptions, whether you have independent support for your projections, and any uncertainties and limitations on your projections. In addition, disclose net income (loss) and earnings (loss) per share. For guidance, see Item 10 of Regulation S-K.
No reply letter found.
Please expand the appropriate section to discuss, if material, the "certain trading operations" mentioned in the first paragraph on page F-9.
No reply letter found.
Please expand the disclosure in this risk factor to state the percentage of goodwill and intangible assets compared to your total assets.
No reply letter found.
Once you have identified your named executive officers and directors, please revise the disclosure on page 37 to identify your officers and directors that are located outside of the United States. Also, include a separate "Enforceability" section addressing the challenges of bringing actions and enforcing judgments and liabilities against such individuals.Rest of the question
If the Separation and Distribution, together with certain related transactions, page 42
No reply letter found.
Please revise here and on page 56 to clarify that the condition that you receive an opinion from outside counsel is a waivable condition, if true.
No reply letter found.
You disclose that certain of your executive officers and directors may have actual or potential conflicts of interest. Please briefly describe these actual or potential conflicts of interest in more detail in an appropriate place in your registration statement.Rest of the question
Certain entities or assets that are part of the separation may not be transferred, page 45 You disclose that certain entities and assets may not be transferred prior to the distribution because they are subject to foreign government or third-party approvals, and you cannot assure such transfers will ultimately occur or not be delayed for an extended period of time. Please describe more fully the entities and assets involved, as well as the foreign government and third-party approvals that are required. 9. Capitalization, page 67 10. Please revise your capitalization table to address the following: • Separate the line item “cash and cash equivalents” with a double underline to clearly separate it form your capitalization. • Replace “total liabilities” with details of your long term debt and current maturities of long term debt. • Remove “total liabilities and equity” as that amount should be the same as "total capitalization." Management's Discussion and Analysis of Financial Condition and Results of Operations Results of Operations, page 74 11. Please expand your disclosures to clearly communicate the extent to which your revenue variances were impacted by changes in prices and by changes in sales volume. See the related guidance in Item 303(b)(2)(iii) of Regulation S-K. For example, on page 79 you disclose that the increase in Building Materials segment revenues in 2023 was mainly attributable to improved organic growth in volumes in cement and aggregates and improved price growth across most markets and product lines. Please separately quantify the amount related to change in price versus change in volume. Additionally, please quantify any offsetting factors, such as the decline in revenue from commercial roofing systems in 2023 which offset the overall increase in Building Envelope segment revenues. Intellectual Property, page 96 12. We note the disclosure in this section about trademarks and patents. Please expand your disclosure to include a discussion of the duration and effects of your trademarks and patents. See Item 101(c)(iii)(B) of Regulation S-K. Legal Proceedings, page 100 13. Please tell us why the disclosure in this section does not mention the disclosure in Note 15 on page 43 of Holcim's 2024 Half-Year Report on Holcim's website. Executive and Director Compensation, page 107 14. Please revise to provide the information for the fiscal year ended 2023 in your next amendment, if you have identified your named executive officers and directors. Tax Matters Agreement, page 111 15. Please revise to disclose the expected duration of the limitations you will be subject to as a result of the Tax Matters Agreement. Please quantify the scope of the indemnification obligations to Parent or otherwise supplement your disclosure to provide stockholders with sufficient information to assess the materiality of these obligations. Notes to Combined Financial Statements Note 3 - Revenue, page F-21 16. You disclose on page F-11 that a performance obligation may be satisfied at a point in time, usually for promises to transfer goods, or over time, typically for promises to transfer services or for construction-related activities. Please tell us how you considered the guidance to disaggregate revenue into categories that depict how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors, e.g., type of revenue (i.e., product and service) and timing (i.e., at a point in time and over time). Refer to ASC 606-10-50-5 and also see ASC 60610-55-89 through 91. Note 8 - Goodwill and Intangible Assets, Net, page F-29 17. You disclose that based upon the results of the qualitative and quantitative assessments, you concluded that the fair values of each of your reporting units as of December 31 2023, 2022, and 2022 were greater than their carrying values. Please revise to state whether the fair values of your reporting units “substantially exceed” the respective carrying values. To the extent any reporting unit fair values are not substantially in excess of carrying values, please revise your Critical Accounting Policies and Estimates section of MD&A to disclose the name(s) of the reporting unit(s), the percentage by which the estimated fair value of the reporting unit(s) exceeded the carrying value, the amount of goodwill allocated to the reporting unit(s), and whether the related goodwill is at risk of impairment. Also provide a description of potential events and/or changes in circumstances that could reasonably be excepted to negatively affect the key assumptions. See guidance in Item 303(b)(3) of Regulation S-K. Note 17. Commitments and Contingencies, page F-48 18. We note your disclosure on page F-48 that consistent with industry practice, the Company provides warranties on many of its products. We also note the disclosure that you estimate future warranty costs based on historical trends and product sales, but may fail to accurately estimate those costs. Please revise your notes to the financial statements to include disclosures required by ASC 460-10-50-8, if material. Exhibits 19. Please file material contracts required by Item 601(b)(10) of Regulation S-K as exhibits to your registration statement, such as material debt financing transactions and material commercial agreements. General 20. The cross-reference sheet between the Information Statement and items of Form 10 omits a number of sections of the Information Statement, such as the Questions and Answers section. Please revise to specifically incorporate by reference the sections. We note that your Information Statement includes a number of blanks and references to information that will be filed by amendment. Please fill in these blanks and missing information with your next amendment or tell us why you are unable to do so and when 21. you expect to have this information. We may have further comments when we have reviewed the additional disclosure.
No reply letter found.
Refer to Adjustment (e). Please identify the adjustment on the face of the pro forma financial statements. Refer to Adjustment (c). We note your disclosure that for this pro forma adjustment, you have assumed for this purpose that holders of 20% of the bonds will not accept the debt-for-debt exchange offer (and that holders of 80% of the bonds will accept the 2.Rest of the question
debt-for-debt exchange offer), except for $50 million of bonds due in 2031, where you have assumed that holders of 100% of the bonds will consent to an issuer/guarantor substitution. Please note that Rule 11-02(a)(10) of Regulation S-X requires that if significantly different results may occur, you should provide additional pro forma presentations which give effect to the range of possible results. Please advise or revise accordingly. Autonomous Entity Adjustments, page 80 3. Refer to Adjustment (i). Please revise to discuss the material assumptions used and how the amount was calculated or determined. See Rule 11-2(a)(11)(iii) of Regulation S-X. 4. Refer to Adjustment (j). Please note that autonomous entity adjustments reflect changes in your costs resulting from agreements in place. Changes in costs that are not evidenced by agreements in place would ordinarily not be autonomous entity adjustment. Tell us your basis for including one-time stand-up costs expected to be incurred as autonomous entity adjustment. Management Adjustments, page 80 5. We note your management adjustments include recurring costs required to operate new functions as a public company. Please clarify whether these costs include costs reflected in Adjustment (i) that are related to the Transition Services Agreement.
No reply letter found.
Please revise the summary pro forma combined statement of operations to include earnings per share and weighted average shares on a pro forma basis.
The Company respectfully acknowledges the Staff’s comment and has included earnings per share and weighted average shares on a pro forma basis in the summary pro forma condensed combined statement of operations information on page 13 of Amendment No. 1.Read in the reply
Refer to footnotes (a), (b) and (c) for the pro forma adjustments to cash and cash equivalents and long-term debt. Please revise to present a reconciliation in tabular format of the multiple components that aggregate to the total pro forma balance sheet adjustments to cash and long-term debt, respectively. Refer to footnote (b).Rest of the question
You disclose that the revolving credit facility is not expected to be utilized upon the completion of the Spin-Off. Please revise to also disclose whether the commercial paper program and the bridge loan are expected to be utilized upon the completion of the Spin-Off and how is the utilization reflected in the pro forma 3. financial statements, if applicable.
The Company respectfully acknowledges the Staff’s comment and has revised footnote (c) on page 84 and page 85 of Amendment No. 1 to present reconciliations in tabular format of the treasury adjustments described in footnotes (a) and (c) that aggregate to the total pro forma balance sheet adjustments to Cash and cash equivalents and Long-term debt. There is no pro forma adjustment impact to Cash and cash equivalents and Long-term debt from the treasury adjustments described in footnote (b) based on the Company entering certain transactions prior to the March 31, 2025 balance sheet date.Read in the reply
Please tell us why you have not filed as exhibits the Framework Supply Agreement and the Manufacturing and Purchase Agreement mentioned on page 182.
The Company respectfully acknowledges the Staff’s comment and advises the Staff that the Framework Supply Agreement and the Manufacturing and Purchase Agreement are not material to the Company and theRead in the reply
Company does not believe such agreements are required to be filed under Item 601(b)(10) of Regulation S-K.
Framework Supply Agreement
The Framework Supply Agreement will govern the relationship between the Company and Holcim pursuant to which the Company may purchase Holcim’s cement exports to the United States on an arm’s length basis and on market terms.Rest of the answer
The purpose of the Framework Supply Agreement is simply to provide the Company with an alternative supply of cementitious products in the event that the Company is unable to satisfy demand for cementitious products from its own production facilities. If the Framework Supply Agreement were terminated, the Company believes that it would have reasonable access to purchase cementitious products on similar terms from alternative sources, and that it would not be at a risk of inadequate supply of a key input. Accordingly, the Company believes that the Framework Supply Agreement is immaterial in significance.
The Company also believes that the Framework Supply Agreement is immaterial in amount. The Company expects the purchases of cement products from Holcim under the Framework Supply Agreement to annually result in approximately $92.6 million of expenses for the Company and approximately $92.6 million of revenue for Holcim, which represents approximately 1% of the $8.6 billion cost of revenues (i.e., expenses) incurred by the Company during the year ended
December 31, 2024. Given that the purpose of the Framework Supply Agreement is to provide the Company with a supply of cementitious products in order to satisfy demand from the Company’s customers, any expenses incurred by the Company pursuant to the
Framework Supply Agreement are expected to be offset by revenue from such third-party customers.
Manufacturing and Purchase Agreement
The Manufacturing and Purchase Agreement will govern the relationship between the Company and Holcim pursuant to which the Company will manufacture and sell to Holcim certain products related to the Company’s portfolio of residential and commercial building performance solutions — including roofing, wall and lining products — on an arm’s length basis and on market terms. The purpose of the Manufacturing and Purchase Agreement is to provide Holcim with the ability to purchase from the Company, and sell to its customers, certain products that will be manufactured only by the Company following the Spin-off. If the Manufacturing and Purchase Agreement were terminated, Holcim would be unable to offer these products to its customers (who are outside of the United States and Canada), but the Company would either sell these products to these customers outside of the United States and Canada on a direct basis or offset the lost revenue by repurposing a portion of its manufacturing capabilities. Accordingly, the Company believes that the Manufacturing and Purchase Agreement is immaterial in significance.
The Company also believes that the Manufacturing and Purchase Agreement is immaterial in amount. The Company expects the Manufacturing and Purchase Agreement to result in revenue from Holcim of approximately $71.5 million per year, which represents less than 1% of the $11.7 billion of revenue generated by the Company during the year ended December 31, 2024.
***
Summaries of both the Framework Supply Agreement and the Manufacturing and Purchase Agreement were included in Amendment No. 1 in order to provide full disclosure of all relationships between the Company and Holcim.
However, at the time each agreement becomes effective, Holcim will not be a security holder of the Company and the only relationships between Holcim and the Company will be those described in the Registration Statement.
We hope that the foregoing has been responsive to the Staff’s comment and look forward to resolving any outstanding issues as quickly as possible. Please direct any questions or comments regarding the foregoing to me at
(212) 735-3743 or [email protected].
Also in this review: company letter, May 28, 2025